Report
ABGSC Healthcare Research ...
  • Morten Larsen

Lowly Q1 on the cards; healthy fundamentals

Embla (name change from Ossur) reports Q1 on 23 April in the morning. Solid start to 2024 with 5% Q1e organic growth, held back by tough comps. Estimates 1-2% down on FX, FV reiterated at DKK 25-37.
Underlying
Provider
ABG Sundal Collier Sponsored
ABG Sundal Collier Sponsored

ABG Sundal Collier is the independent, Nordic investment banking powerhouse, developed over 30 years, founded on a hard working partnership culture and the ability to attract top talent.

Our strategy is to be an advisor and an intermediary, and the core product offering comprise corporate advisory services, corporate financing services and investor research and brokerage services.

Our corporate advisory team offers access to a broad financial and industrial network and unparalleled transaction experience. We provide financing to corporates through our superior Nordic and international distribution platform, and we are optimally structured for naturally matching trading flows, delivering best execution for clients.

The group employ approx. 250 staff working from the Nordic offices in Norway, Sweden and Denmark and in the offices in the key international markets US, UK and Germany. 


Analysts
ABGSC Healthcare Research

Morten Larsen

Other Reports on these Companies
Other Reports from ABG Sundal Collier Sponsored
ABGSC Telecom Operators Research ... (+3)
  • ABGSC Telecom Operators Research
  • Daniel Thorsson
  • Simon Granath
ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Georg Tigalonov-Bjerke
ABGSC IT Research ... (+4)
  • ABGSC IT Research
  • Dafina Shehu
  • Daniel Thorsson
  • Nikola Kalanoski

ResearchPool Subscriptions

Get the most out of your insights

Get in touch